Pfizer raised its annual forecasts on Tuesday as strong demand for its cancer drugs and blockbuster blood thinner Eliquis helped the drugmaker post better-than-expected third-quarter results. The U.S.
In today’s newsletter: Ping Yeh, Dan Que Pham, Ali Khammanivong, Thomas Sheehan, Neal Lackritz joins The Toro Company, Sen. Amy Klobuchar, Speaker Lisa Demuth, Ed Bastian, Geoff Martha, Christophe ...
Genmab's late-stage cancer trial wins boost its strategy to own and co-own more drugs, doubling its stock as investors eye stronger prospects.
Genmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.
Diagnostics company Immunovia said a study of its PancreaSure blood test has been selected for an oral presentation at the CGA-IGC scientific conference in Denver, USA, on November 3.The ...
The Hyderabad-based startup’s new RNA Foundry will design custom tumour-targeting vaccines, but the tech remains strictly experimental. Founder and CEO Soham Sankaran explains how the process works an ...
For the federated analysis between the UK and Singapore, the Singapore TRE requires a standalone R script that will produce the same result on the same data as a 5s-TES analysis in the UK TRE(s?). The ...
BioNTech has spent October stacking up oncology readouts, and the month's mixed scorecard now hands the narrative to its third-quarter report. The company has slated results for Q3 2026 and a ...
Multiple linear regression in R on 2,000 cancer risk profiles: model building, interaction tests, VIF and diagnostics. - ROSINA365/cancer-risk-regression-r ...
The NHS has announced that an additional one million scans have been delivered across England, thanks to the introduction of more scanners in hospitals nationwide. This development allows patients to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results